Inherited genetic variants associated with occurrence of multiple primary melanoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 6, 2015, Pages 992-997

  Begg, Colin B ^b   Orlow, Irene ^b   Busam, Klaus J ^b   Reiner, Anne S ^b   Roy, Pampa ^b   Sharma, Ajay ^b   La Pilla, Emily ^b   Berwick, Marianne ^d   Luo, Li ^d   White, Kirsten ^d   Paine, Susan ^d   Armstrong, Bruce K ^e,m   Kricker, Anne ^e,m   Cust, Anne E ^e,m   Venn, Alison ⁿ   Dwyer, Terence ^k,n,o   Tucker, Paul ⁿ   Gallagher, Richard P ^i,p   Kan, Donna ^p   Marrett, Loraine D ^h   Theis, Elizabeth ^h   From, Lynn ^h,l   Zanetti, Roberto ^q   Rosso, Stefano ^j,q   Anton Culver, Hoda ^f   Ziogas, Argyrios ^f   Gruber, Stephen B ^g,r   Johnson, Timothy ^r   Sturgeon, Duveen ^r   Thomas, Nancy E ^a   Millikan, Robert C ^a   Ollila, David W ^a   Conway, Kathleen ^a   Groben, Pamela A ^a   Edmiston, Sharon N ^a   Hao, Honglin ^a   Parrish, Eloise ^a   Gibbs, David C ^a   Frank, Jill S ^a   Bramson, Jennifer I ^a   Rebbeck, Timothy R ^s   Kanetsky, Peter A ^c,s   Taylor, Julia Lee ^t   Madronich, Sasha ^t   more..

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h CANCER CARE ONTARIO   (Canada)

ⁱ BRITISH COLUMBIA CANCER AGENCY   (Canada)

^j Cancer Epidemiology Unit of the Centre for Cancer Epidemiology and Prevention   (Italy)

^k UNIVERSITY OF OXFORD   (United Kingdom)

^l WOMEN S COLLEGE HOSPITAL   (Canada)

^m UNIVERSITY OF SYDNEY   (Australia)

ⁿ UNIVERSITY OF TASMANIA   (Australia)

^o UNIVERSITY OF OXFORD   (United Kingdom)

^p BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^q CPO Piedmont   (Italy)

^r UNIVERSITY OF MICHIGAN   (United States)

^s UNIVERSITY OF PENNSYLVANIA   (United States)

^t NATIONAL CENTER FOR ATMOSPHERIC RESEARCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; MULTIPLE PRIMARY MELANOMA; PHENOTYPE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE PRIMARY MELANOMA; AUSTRALIA; CANADA; CANCER STAGING; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; EUROPE; FOLLOW UP; GENETICS; GENOME-WIDE ASSOCIATION STUDY; INTERNATIONAL COOPERATION; MULTICENTER STUDY; PATHOLOGY; PROGNOSIS; SKIN NEOPLASMS; TUMOR INVASION; UNITED STATES;

TUMOR MARKER;

AUSTRALIA; BIOMARKERS, TUMOR; CANADA; CASE-CONTROL STUDIES; EUROPE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; INTERNATIONAL AGENCIES; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; SKIN NEOPLASMS; UNITED STATES;

EID: 84941795656     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-1426     Document Type: Article

References (23)

1. Ferrone CR, Ben Porat L, Panageas KS, Berwick M, Halpern AC, Patel A, et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA 2005;294:1647-54.
2. Uliasz A, Lebwohl M. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma. Int J Dermatol 2007; 46:575-7.
3. Law MH, MacGregor S, Hayward NK. Melanoma genetics: recent findings take us beyond well-traveled pathways. J Invest Dermatol 2012;132: 1763-74.
4. Gerstenblith MR, Shi J, Landi MT. Genome-wide association studies of pigmentation and skin cancer: a review and meta-analysis. Pigment Cell Melanoma Res 2010;23:587-606.
5. Gudbjartsson DF, Sulem P, Stacey SN, Goldstein AM, Rafnar T, Sigurgeirsson B, et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 2008;40:886-91.
6. Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, Corda E, et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 2009;41:920-5.
7. Nan H, Xu M, Zhang J, Zhang M, Kraft P, Qureshi AA, et al. Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk. Hum Mol Genet 2011;20:2673-9.
8. Barrett JH, Iles MM, Harland M, Taylor JC, Aitken JF, Andresen PA, et al. Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet 2011;43:1108-13.
9. Amos CI, Wang LE, Lee JE, Gershenwald JE, Chen WV, Fang S, et al. Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet 2011;20:5012-23.
10. Jannot AS, Meziani R, Bertrand G, Gerard B, Descamps V, Archimbaud A, et al. Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma. Eur J Hum Genet 2005;13:913-20.
11. Zhang W, Chen Y, Yang X, Fan J,Mi X, Wang J, et al. Functional haplotypes of the hTERT gene, leukocyte telomere length shortening, and the risk of peripheral arterial disease. PLoS One 2012;7:e47029.
12. Fernandez LP, Milne RL, Pita G, Aviles JA, Lazaro P, Benitez J, et al. SLC45A2: a novel malignant melanoma-associated gene. Hum Mutat 2008;29:1161-7.
13. Macgregor S, Montgomery GW, Liu JZ, Zhao ZZ, Henders AK, Stark M, et al. Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nat Genet 2011;43:1114-8.
14. Millikan RC, Hummer A, Begg C, Player J, de Cotret AR, Winkel S, et al. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. Carcinogenesis 2006;27:610-8.
15. Begg CB, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, et al. A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol 2006;35: 756-64.
16. Orlow I, Roy P, Reiner AS, Yoo S, Patel H, Paine S, et al. Vitamin D receptor polymorphisms in patients with cutaneous melanoma. Int J Cancer 2012; 130:405-18.
17. Barrett JC, Fry B, Maller J, Daly MJ.Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
18. International HapMap C. The International HapMap Project. Nature 2003;426:789-96.
19. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003;73: 1162-9.
20. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002; 53:79-91.
21. Chatzinasiou F, Lill CM, Kypreou K, Stefanaki I,Nicolaou V, SpyrouG, et al. Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma. J Natl Cancer Inst 2011; 103:1227-35.
22. Pena-Chilet M, Blanquer-Maceiras M, Ibarrola-Villava M, Martinez-Cadenas C, Martin-Gonzalez M, Gomez-Fernandez C, et al. Genetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes associated with melanoma susceptibility in a Spanish population. BMC Cancer 2013;13:160.
23. Helsing P, Nymoen DA, Rootwelt H, Vardal M, Akslen LA, Molven A, et al. MC1R, ASIP, TYR, and TYRP1 gene variants in a population-based series of multiple primary melanomas. Genes Chromosomes Cancer 2012;51: 654-61.